Harbin Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd.verified

600664.SS

Price:

$3.59

Market Cap:

$9.04B

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin products, as well as intermediates. The company's lead products include Shuang Huanglian freeze-dried injection; Danshen freeze-dried injection; Shuang Huanglian powder for injection; roxithromycin dispersible tablets; belladonna, sulfamethoxazole, and trimerhoprim tablets; pediatric para...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

1993-06-29

Stock Exchange

SHH

Ticker

600664.SS

The PE Ratio as of December 2025 (TTM) for Harbin Pharmaceutical Group Co., Ltd. (600664.SS) is 19.94

According to Harbin Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 19.94. This represents a change of -32.74% compared to the average of 29.65 of the last 4 quarters.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Historical PE Ratio (quarterly & annually)

How has 600664.SS PE Ratio performed in the past?

The mean historical PE Ratio of Harbin Pharmaceutical Group Co., Ltd. over the last ten years is 38.96. The current 19.94 PE Ratio has changed 5.02% with respect to the historical average. Over the past ten years (40 quarters), 600664.SS's PE Ratio was at its highest in in the March 2017 quarter at 95.13. The PE Ratio was at its lowest in in the September 2020 quarter at -57.24.

Quarterly (TTM)
Annual

Average

38.96

Median

25.24

Minimum

-7.42

Maximum

189.50

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Harbin Pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 615.09%

Maximum Annual PE Ratio = 189.50

Minimum Annual Increase = -423.19%

Minimum Annual PE Ratio = -7.42

Quarterly (TTM)
Annual
YearPE RatioChange
202416.52-22.03%
202321.1930.09%
202216.29-32.09%
202123.98-423.19%
2020-7.42-103.92%
2019189.50615.09%
201826.50-27.02%
201736.3135.43%
201626.81-32.80%
201539.90-40.24%

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Average PE Ratio

How has 600664.SS PE Ratio performed in the past?

The current PE Ratio of Harbin Pharmaceutical Group Co., Ltd. (600664.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

18.00

5-year avg

14.11

10-year avg

38.96

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) PE Ratio vs. Peers

How is 600664.SS’s PE Ratio compared to its peers?

Harbin Pharmaceutical Group Co., Ltd.’s PE Ratio is less than Shandong Xinhua Pharmaceutical Company Limited (28.63), less than Tianjin Ringpu Bio-Technology Co.,Ltd. (21.27), greater than Cisen Pharmaceutical Co., Ltd. (16.62), greater than Renhe Pharmacy Co., Ltd. (18.25), less than Zhejiang Xianju Pharmaceutical Co.,Ltd. (33.22), greater than KPC Pharmaceuticals, Inc. (17.79), less than Shandong Lukang Pharmaceutical Co.,Ltd. (43.85), less than Sichuan Huiyu Pharmaceutical Co., Ltd. (167.17), less than Northeast Pharmaceutical Group Co., Ltd. (20.46), less than Jiangsu Kanion Pharmaceutical Co.,Ltd. (34.81),

Build a custom stock screener for Harbin Pharmaceutical Group Co., Ltd. (600664.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harbin Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harbin Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Harbin Pharmaceutical Group Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Harbin Pharmaceutical Group Co., Ltd. (600664.SS)?

What is the highest PE Ratio for Harbin Pharmaceutical Group Co., Ltd. (600664.SS)?

What is the 3-year average PE Ratio for Harbin Pharmaceutical Group Co., Ltd. (600664.SS)?

What is the 5-year average PE Ratio for Harbin Pharmaceutical Group Co., Ltd. (600664.SS)?

How does the current PE Ratio for Harbin Pharmaceutical Group Co., Ltd. (600664.SS) compare to its historical average?